TL;DR
- The median B2B SaaS sales cycle is 84 days (Optifai, 2025), but SMB deals under $10K close in 14–30 days and enterprise deals over $150K take 6–12 months. The average hides a 10x range.
- Sales cycles have lengthened 22% since 2022 (Optifai, 2025), driven by buying committees growing from 5.4 to 6.8 stakeholders and expanded security due diligence on all enterprise deals.
- Win rate drops from 47% to 21% when deals extend past 50 days (Outreach, 2025). Speed is not just efficiency — it is a direct predictor of whether the deal closes at all.
- Multi-threading before Stage 3 raises win rates by 130% on deals over $50K ACV (Gong, 2025). Single-threaded deals are the single highest-leverage factor adding weeks to the average cycle.
- The biggest cycle accelerator is pre-call preparation that surfaces signals, stakeholders, and account history before every touchpoint — compressing research time from 45 minutes to under 5 minutes per deal.
Direct answer
Sales cycle length benchmark figures for 2026: the median B2B SaaS cycle is 84 days, professional services averages 63 days, manufacturing averages 120 days, and healthcare averages 140 days. Deal size is the strongest predictor: sub-$10K ACV closes in 14–30 days, $10K–$50K ACV in 45–90 days, and $50K+ ACV in 90–180 days or longer. Cycles have lengthened 22% since 2022 across all segments.
What is sales cycle length — and why the average number misleads you
Sales cycle length is the number of days between opportunity creation and closed-won. The formula is simple: add up total days across all closed deals in a period, then divide by the number of deals closed. The result is your average. Track it separately for SMB, mid-market, and enterprise — a blended average across segments is almost useless for diagnosis.
The "average" B2B sales cycle cited in most benchmark reports sits at 84 days. That number comes from Optifai's 2025 SaaS analysis and reflects the median opportunity-to-close duration for B2B software deals. But the median hides what actually matters. A team selling to SMB HR buyers and a team selling to enterprise security buyers are not operating in the same universe. When an enterprise deal runs 270 days, it pulls the average up. When a high-velocity inside sales team closes in 10 days, it pulls the average down. Neither rep learns anything useful from the blended number.
The Formula
Measure from opportunity creation date, not from first marketing touch. Measure to closed-won date, not to contract signature (those can lag by days or weeks). Segment before comparing.
Why the average misleads: 57% of sales teams report their average sales cycle is getting longer (Prospeo, 2026). Cycles have grown 22% since 2022, per Optifai. But if you only track the blended average, you cannot see which segment is slowing down. A growing enterprise business will show a rising average even if the SMB team is getting faster. The diagnostic value comes from segmented measurement. Sales cycle length is one of the five metrics every CRO dashboard should track by segment, not just in aggregate.
The second thing most benchmark articles skip: opportunity creation date definition matters enormously. Some teams create opportunities at first contact. Others create them at discovery call booked. Others create them at ICP-qualified stage. The benchmark you compare against is only valid if your definition matches theirs. Optifai's 84-day figure starts at opportunity creation, not at first cold touch. The SaaStr ACV-based benchmarks below start at the first substantive sales conversation, not at marketing attribution. Know your denominator before comparing.
Sales cycle length benchmark by industry: SaaS, fintech, healthcare, manufacturing, professional services
Industry is the first cut to make when evaluating your cycle length. A 90-day cycle is aggressive for healthcare and slow for professional services. The table below compiles benchmarks from Optifai (2025), Prospeo (2026), folk.app (2025), focus-digital.co (2025), and Databox (2022). Where sources conflict, this report uses the most recent figure and flags the divergence.
| Industry | SMB | Mid-Market | Enterprise | Overall Median | Sources |
|---|---|---|---|---|---|
| SaaS (B2B) | 14–30 days | 45–90 days | 6–12 months | 84 days (median) | Optifai, 2025; orm-tech.com, 2026 |
| Fintech | 30–60 days | 90–120 days | 9–18 months | ~105 days | Prospeo, 2026; focus-digital.co, 2025 |
| Healthcare / MedTech | 60–90 days | 120–180 days | 12–24 months | ~140 days | SifthHub, 2025; Databox, 2022 |
| Manufacturing | 45–75 days | 90–150 days | 9–15 months | ~120 days | Prospeo, 2026; folk.app, 2025 |
| Professional Services | 21–45 days | 60–90 days | 4–8 months | ~63 days | folk.app, 2025; Databox, 2022 |
SaaS: The 84-day median (Optifai, 2025) is the most cited benchmark in the category, but it includes deals from $5K to $500K ACV in a single number. SMB SaaS deals under $15K should close in 14–30 days according to both SaaStr and Optifai. Series A startups selling to mid-market typically see 45–90 day cycles (cactusmarketing.io, 2025). Enterprise SaaS deals at $100K+ ACV routinely run 6–12 months, with security review and legal adding 30–60 days to what would otherwise be a 90-day deal.
Fintech: Regulatory due diligence is the primary cycle extender. A fintech platform selling to a regional bank faces compliance review on top of standard security assessment. For B2C fintech selling to SMB merchants, the cycle compresses closer to SaaS benchmarks. For infrastructure fintech (payment rails, compliance APIs) targeting financial institutions, 9–18 months at enterprise is the norm.
Healthcare and MedTech: The longest cycles in the B2B world. Clinical validation requirements, HIPAA compliance review, hospital procurement processes, and committee-based purchasing all compound. A SaaS tool selling to a single clinic closes in 60–90 days. A platform selling to a health system closes in 12–24 months. For B2B deals over $250K, 100% now take over six months to close (SifthHub, 2025).
Manufacturing: Longer than SaaS due to capital expenditure approval cycles, plant-level adoption requirements, and multi-location rollout considerations. SMB manufacturing deals (equipment, tooling software, workflow tools) close in 45–75 days. Large enterprise deals involving ERP integration or factory-floor deployment can run 9–15 months.
Professional Services: The fastest median of the five categories at approximately 63 days (folk.app, 2025). Shorter for smaller engagements and teams that operate as trusted advisors to existing clients. Longer for new-logo enterprise contracts or statement-of-work deals requiring legal review. SOW negotiation adds 10–30 days on top of the commercial close.
Sales cycle length benchmark by deal size: under $10K, $10–50K, $50K+
Deal size is the most reliable single predictor of sales cycle length — more reliable than industry, company size, or lead source. The SaaStr benchmarks published by Jason Lemkin and validated by multiple downstream sources show a clean progression: ACV doubles, cycle approximately doubles. The pattern holds across industries because the underlying driver is not product complexity — it is buying process complexity, which scales with budget authority and risk surface.
| ACV Tier | Typical Cycle | Discovery → Evaluation | Evaluation → Legal/Close | Notes |
|---|---|---|---|---|
| Under $10K ACV | 14–30 days | 3–7 days / 5–10 days | 3–7 days | Often 1–2 call closes; self-serve or high-velocity inside sales |
| $10K–$50K ACV | 45–90 days | 7–14 days / 21–45 days | 7–21 days | Mid-market motion; 2–4 stakeholders; requires mutual action plan |
| $50K–$150K ACV | 90–180 days | 14–30 days / 60–90 days | 14–45 days | Enterprise-lite; legal and security review standard at this tier |
| $150K–$500K ACV | 6–12 months | 21–45 days / 120+ days | 30–90 days | Full enterprise; RFP, procurement, and infosec common; 6–13 stakeholders |
| $500K+ ACV | 12–24 months | 30–90 days / 270+ days | 60–180 days | Strategic deals; executive sponsorship required; board-level approval likely |
The most important insight from deal-size data: the evaluation stage — not the discovery stage — is where cycles inflate. Discovery time across ACV tiers stays relatively compressed. What varies is how long the prospect spends validating the decision internally, running security review, getting legal to approve the MSA, and managing internal stakeholder alignment. A rep can accelerate discovery by being prepared. The rep has far less control over how fast procurement moves.
What this means for reps
If a deal is running 50% longer than the ACV benchmark, the cause is almost always in the evaluation stage: the champion does not have executive sponsorship, procurement was never scoped, or the deal is competing against a status-quo decision of doing nothing. The fix is a mutual action plan that names every stakeholder, every approval step, and the specific compelling event that makes inaction costly. See the full diagnosis in why deals slip every quarter.
Sales cycle benchmarks by company stage: Seed, Series A, Series B, and growth
Company stage — both the selling company's stage and the buying company's stage — shapes cycle length. Early-stage sellers typically close faster because the founder is in the room, the ICP is narrow, and the first customers are warm network closes. As companies scale, they expand ICP, add enterprise segments, and install sales processes that slow the average cycle while increasing average ACV.
| Seller Stage | Dominant Motion | Typical Avg Cycle | What Drives the Number |
|---|---|---|---|
| Seed / Pre-PMF | Founder-led outbound | 21–60 days | ICP still being validated; high variance; short wins from warm network |
| Series A | First sales hires | 45–90 days | Repeatable motion emerging; cycles lengthen as ICP expands beyond network |
| Series B | Segmented team | 60–120 days | SMB and mid-market split; processes forming; first RevOps hires |
| Series C+ | Full go-to-market | 90–180 days | Enterprise push lengthens avg; multi-stage deals become majority of pipeline |
| Public / Scale | Enterprise-first | 120–270 days | Legal, security, procurement standard; dedicated deal desk at this stage |
The buying side matters too. Selling to a Seed-stage startup versus a Series C company changes the decision dynamics even if the ACV and product category are identical. The Seed buyer decides in days. The Series C buyer routes through VP approval, then legal, then IT. The enterprise buyer adds procurement and a committee of 6–13 stakeholders. This is why industry benchmarks that aggregate all buyer sizes produce averages that do not reflect any individual seller's reality. Understanding the B2B buying committee structure is the prerequisite to setting accurate cycle forecasts.
For founder-led sales at Seed stage: the benchmark is irrelevant. The founder's cycle is as short as the relationship and product conviction allow. Cycles of 7–21 days are common and expected at this stage. The benchmark becomes relevant when a company hires its first reps and needs to set realistic forecasts, quota, and ramp expectations based on the market they are actually selling into.
What lengthens the sales cycle — the seven factors reps can actually control
Sales cycles have lengthened 22% since 2022 (Optifai, 2025). The primary cause: buying committees grew from an average of 5.4 stakeholders to 6.8 stakeholders per deal. Each additional stakeholder adds a decision node, a potential blocker, and a coordination delay. But buying committee growth is a market condition, not something reps can change directly. The seven factors below are ones that reps and sales leaders can actually influence.
| Factor | Impact | Data Point | Rep-Level Fix |
|---|---|---|---|
| Large buying committee | High | 6.8 avg stakeholders in 2026, up from 5.4 in 2022 (Optifai, 2025) | Map all stakeholders at Stage 2, not after Stage 4 |
| Security and compliance review | High | Enterprise deals now averaging +18 days vs. 2022 for security due diligence (Optifai, 2025) | Prepare security questionnaire pack before first meeting |
| Slow follow-up after demos | High | Win rate drops from 47% to 21% when deals pass 50 days (Outreach, 2025) | Send mutual action plan within 24 hours of discovery call |
| Single-threading | High | Multi-threaded deals close at 130% higher win rate on $50K+ ACV (Gong, 2025) | Engage 3+ stakeholders before Stage 3 |
| Vague next steps | Medium | 80% of deals require 5–12 follow-ups; 44% of reps stop at one (GrowthList, 2025) | Every call ends with a named next step and a booked calendar slot |
| No compelling event | Medium | Deals without a defined timeline or trigger close 43% less often (Gangly analysis) | Identify or create the compelling event at discovery |
| Poor CRM hygiene | Medium | 47% of CRM data is inaccurate at any snapshot (Validity, 2022) | Update stage and close date within 24 hours of every touchpoint |
The most controllable factor is follow-up speed. Win rate drops from 47% to 21% when deals extend past 50 days (Outreach, 2025). That 26-point drop is not caused by the buyer losing interest in the category — it is caused by competing priorities accumulating, budget cycles shifting, and champion momentum fading while the deal sits in limbo. The rep who follows up within 24 hours of every touchpoint with a named next step and a calendar invite keeps the deal moving. The rep who sends a "just checking in" email three weeks later is competing against inertia.
Poor CRM hygiene is the silent killer. 47% of CRM data is inaccurate at any snapshot (Validity, 2022). When stage dates, close dates, and stakeholder records are wrong, the rep misses the signal that a deal has stalled. A deal sitting at 45 days in Stage 3 looks fine on the forecast. A deal that has had no activity logged in 14 days is a deal that is dying — but only the rep who tracks last-activity date can see it. If your CRM update problem is eating hours, see the breakdown in why CRM updates take too long and how to fix it.
How to shorten the sales cycle: six tactics that move deals without burning trust
Shortening the sales cycle is not about rushing the buyer. Rushed buyers stall at signing. The goal is removing friction between each stage — eliminating the days that pile up between touchpoints because of poor preparation, missing stakeholders, undefined next steps, or CRM data that does not reflect reality. The six tactics below have the strongest evidence across the benchmark sources used in this report.
Send a mutual action plan within 24 hours of discovery
A mutual action plan names every step from discovery to close, every stakeholder who must be involved, and every date by which each step must complete. Deals with a MAP close 28% faster than deals without one, because the plan makes the buyer's internal process visible to both sides. Without a MAP, the rep has no way to know when procurement review will start. With a MAP, both sides have agreed on a timeline before Stage 2 is complete.
Multi-thread before Stage 3
Multi-threaded deals win at 130% higher rates on deals over $50K (Gong, 2025). The rep who builds relationships with the economic buyer, the technical evaluator, and the legal contact before Stage 3 removes the three most common late-stage stalls: the economic buyer who never saw the deal, the IT team who has security questions, and legal who needs a custom clause. Engage all three at Stage 2. The champion introduction is the critical first move — see the full framework in why multithreading attempts fail and what to do instead.
Surface a compelling event — or create one
A compelling event is a date or milestone that makes inaction costly: a competitor entering the market, a regulatory deadline, a board-level OKR tied to the problem the product solves, or a contract expiration with an incumbent vendor. Deals with no compelling event drift to the right of the forecast indefinitely. Identify the compelling event at discovery. If the buyer does not have one, create it: a pilot deadline, a pricing lock before a rate increase, or a kickoff slot that disappears if the contract is not signed by a specific date.
Prepare a security questionnaire pack before the first meeting
Enterprise deals now average an additional 18 days compared to 2022 due to expanded security due diligence (Optifai, 2025). The rep who anticipates this and brings a completed security questionnaire, SOC 2 report, and penetration test summary to Stage 2 removes 2–3 weeks of review time. For fintech and healthcare deals, add HIPAA documentation and data processing agreements to the pack. Front-loading security removes the most predictable late-stage stall.
End every call with a named next step and a booked calendar slot
80% of deals require 5–12 follow-ups before a decision (GrowthList, 2025). 44% of reps quit after one touch. The rep who ends every call with a specific next action — "I will send the ROI model by Thursday, and we will review it on Tuesday at 2 PM EST with you and your CFO" — keeps the deal on a defined timeline. A vague close — "I will follow up next week" — is a deal that will be chasing a non-responsive buyer next week. Every missed calendar slot adds 7–10 days to the average cycle.
Run deeper pre-call prep to recover time lost between touchpoints
Every touchpoint that requires the rep to spend 30–45 minutes researching account history before the call adds latent delay: the rep schedules fewer calls, burns more time, and misses signals visible in activity data that would change the conversation. Pre-call preparation that surfaces CRM history, stakeholder context, and recent account signals in under 5 minutes allows reps to run 3–4x more high-quality touchpoints per day. That compounds into a materially shorter average cycle. The specific signals that indicate when to accelerate or re-prioritize a deal are covered in signal-based selling for B2B reps.
The Cycle Velocity Framework: Gangly's model for compressing every stage
Most sales teams measure cycle length as a lagging indicator: they close the quarter, calculate the average, and observe that cycles are getting longer. That observation arrives too late to change the deals that already closed long. The Cycle Velocity Framework measures cycle health as a leading indicator — tracking the rate of stage progression per deal, not the total duration after close.
The Cycle Velocity Framework — 4 Leading Indicators
How long each open deal has been in its current stage. Any deal exceeding 1.5x the benchmark for that stage and ACV tier is a velocity risk — not a closed risk, a velocity risk.
Action: Flag at 1.5x benchmark. Intervene with a specific next step or stage reset.
How many days since the last logged activity on an open deal. A deal with no activity in 10+ days is drifting. A deal with no activity in 21+ days is likely dead but not yet marked closed-lost.
Action: Surface any deal with 10+ days of no activity. Require a same-day action from the rep.
How many named stakeholders are logged against the deal compared to the average buying committee size for that ACV tier. A $75K deal with one contact is a 5-person committee problem waiting to surface at Stage 4.
Action: Require 3+ stakeholders on every deal over $25K before Stage 3.
Whether a specific compelling event with a date is attached to the deal record. Deals without a dated compelling event have no natural forcing function and drift to the right indefinitely.
Action: Required field in CRM for any deal over $10K. No named CE = no Stage 3 progression.
Gangly surfaces all four of these signals automatically. Before every call, Gangly compiles a pre-call brief that includes days-in-stage, last-activity gap, stakeholder coverage, and whether a compelling event date is logged — pulled from the CRM and enriched with recent account signals. The rep walks into every call already knowing whether the deal is on pace or at risk, without spending 30–45 minutes in Salesforce the night before.
The result: reps spend their preparation time deciding how to accelerate the deal, not discovering that it needs acceleration. A rep who knows at 9 AM that a deal has been in Stage 3 for 22 days with no activity can make a same-day outreach decision. A rep who only discovers this during Friday's pipeline review has already lost 5 business days of potential intervention time. Over a quarter, that difference compounds into a materially different average cycle length.
For teams tracking this formally: Gangly's analysis of deal timing patterns shows that the largest compressible gap in most B2B cycles is not in any single stage — it is in the inter-stage gaps, the days between when one stage ends and the next one formally begins. These gaps are caused by delayed follow-ups, missed calendar slots, and stakeholder additions that were never triggered. The AI sales workflow that connects signal to close is built specifically to eliminate these inter-stage delays by triggering the right outreach at the right moment, automatically.
How to measure and track sales cycle length in your CRM
Most CRMs report average sales cycle length out of the box. The number in the report is usually wrong, or at least misleading, for one of three reasons: opportunity creation date is inconsistently defined across reps, closed-lost deals are excluded from the average when they should be included in a denominator analysis, or the average is calculated across all segments rather than by ACV tier and motion.
4-Step Measurement Protocol
- 1
Standardize opportunity creation date
Pick one definition and enforce it across all reps and deal stages. The most defensible definition: the date the account was first qualified as an active sales opportunity (not first marketing touch, not first meeting booked). Document it. Train to it.
- 2
Segment before calculating
Break the data into at minimum three buckets: SMB (under $25K ACV), mid-market ($25K–$100K ACV), and enterprise ($100K+ ACV). Calculate average cycle length separately for each. Combine them only for board-level reporting where segmented data is too granular.
- 3
Track stage-level velocity, not just total cycle
Build a report that shows median days-in-stage for every open opportunity by ACV tier. Deals spending 2x the median time in Stage 2 are your intervention priorities for the current quarter, not next quarter.
- 4
Set benchmark alerts, not just review-meeting observations
The insight from a Friday pipeline review is a week late. Build automated alerts in your CRM or sales engagement platform for deals that cross 1.5x the benchmark for their stage and tier. Act on the alert the same day, not the next review cycle.
For teams with large pipelines, the most actionable report is a cycle velocity heatmap: a table showing each open deal, its current stage, days in current stage, and a flag comparing days-in-stage to the benchmark for that ACV tier. This report takes 20 minutes to build in Salesforce or HubSpot and surfaces every at-risk deal before the quarter-end sprint begins. It is the most direct application of the benchmark data in this report to a live pipeline. For the full framework on building metrics dashboards that use cycle data, see key sales metrics every CRO dashboard should track.
One more measurement note: track cycle length by lead source. Inbound leads from high-intent content (this article, for example) close 2–3x faster than outbound cold leads. If your CRM blends inbound and outbound cycles in the same average, the inbound deals will make the number look better than the outbound reality. Separate them and compare each source to its own benchmark. The gap between your inbound cycle and your outbound cycle tells you how much friction exists in the cold-start phase of your outbound motion. Full data on B2B sales benchmarks across all categories for 2026 provides context for where cycle length fits in the broader performance picture.
Stay current on sales benchmarks
Gangly publishes sales data and workflow research monthly
Benchmark updates, deal-motion research, and rep-facing tactics. No filler. Unsubscribe any time.
Siddharth Gangal
Founder, Gangly · Building the sales workflow system that connects buying signals to prepared reps across outreach, call prep, live coaching, notes, and CRM updates.
By Siddharth Gangal